Assenagon Asset Management
MLAB icon

Assenagon Asset Management’s Mesa Laboratories MLAB Stock Holding History

Assenagon Asset Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,775
Closed -$1.29M – 1383
2021
Q2 		$1.29M Buy
+4,775
New +$1.21M ﹤0.01% 860
2020
Q2 		– Sell
-2,823
Closed -$638K – 1189
2020
Q1 		$638K Buy
+2,823
New +$696K 0.01% 609

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Assenagon Asset Management's MLAB Position: Q3 2021 in Review

Assenagon Asset Management sold out of Mesa Laboratories (MLAB) in Q3 2021, closing a stake of 4,775 shares — an estimated $1.29M sold.

Assenagon Asset Management first reported a position in MLAB in Q1 2020 and held it in 2 quarters. The position peaked at $1.29M in Q2 2021. 172 funds tracked by Wall St. Rank hold MLAB as of Q3 2021.

  • Assenagon Asset Management reported no remaining Mesa Laboratories position as of Q3 2021 after selling out during the quarter.
  • Assenagon Asset Management sold 4,775 Mesa Laboratories shares in Q3 2021, an estimated $1.29M.
  • Assenagon Asset Management first reported a position in Mesa Laboratories in Q1 2020 and held it in 2 quarters.
  • Assenagon Asset Management's Mesa Laboratories position peaked at $1.29M in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2021.

Based on Assenagon Asset Management's 13F filing for Q3 2021, filed 19 Oct 2021.